TABLE 2.
Cases, n (%) | Controls, n (%) | VE (95% CI) | P Value | |
---|---|---|---|---|
All varicella cases and matched controls | N = 133 | N = 365 | ||
Unvaccinated | 57 (42.9) | 36 (9.9) | Reference | |
1-dose | 56 (42.1) | 181 (49.6) | 83.2 (69.2–90.8) | <0.001 |
2-dose | 20 (15.0) | 148 (40.6) | 93.9 (86.9–97.1) | <0.001 |
Incremental (1-dose recipients as reference) | 63.6 (32.6–80.3) | 0.001 | ||
Moderate/severe cases and matched controls | N = 77 | N = 216 | ||
Unvaccinated | 43 (55.8) | 24 (11.1) | Reference | |
1-dose | 28 (36.4) | 107 (49.5) | 88.2 (72.7–94.9) | <0.001 |
2-dose | 6 (7.8) | 85 (39.4) | 97.5 (91.6–99.2) | <0.001 |
Incremental (1-dose recipients as reference) | 78.6 (40.9–92.3) | 0.003 |
VE indicates vaccine effectiveness; 95% CI, 95% confidence interval.